ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 238 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $60,908,056 | +73.9% | 5,806,297 | +117.8% | 0.01% | +57.1% |
Q3 2023 | $35,028,796 | +100.8% | 2,665,814 | +92.5% | 0.01% | +133.3% |
Q2 2023 | $17,444,637 | -13.7% | 1,384,495 | -10.6% | 0.00% | -25.0% |
Q1 2023 | $20,206,046 | -10.2% | 1,548,356 | +21.4% | 0.00% | -20.0% |
Q4 2022 | $22,505,747 | +45.2% | 1,275,836 | +25.4% | 0.01% | +66.7% |
Q3 2022 | $15,495,000 | +33.3% | 1,017,448 | +29.8% | 0.00% | +50.0% |
Q2 2022 | $11,621,000 | -69.6% | 783,604 | -53.8% | 0.00% | -71.4% |
Q1 2022 | $38,185,000 | -59.0% | 1,695,615 | -66.4% | 0.01% | -53.3% |
Q4 2021 | $93,080,000 | +34.4% | 5,044,976 | -2.6% | 0.02% | +25.0% |
Q3 2021 | $69,238,000 | -24.8% | 5,178,710 | +4.0% | 0.01% | -20.0% |
Q2 2021 | $92,131,000 | +15.9% | 4,977,375 | -6.0% | 0.02% | +7.1% |
Q1 2021 | $79,474,000 | -68.6% | 5,292,953 | -69.8% | 0.01% | -70.2% |
Q4 2020 | $253,470,000 | +49.0% | 17,553,303 | -16.0% | 0.05% | +34.3% |
Q3 2020 | $170,065,000 | +14.2% | 20,892,473 | -5.0% | 0.04% | +6.1% |
Q2 2020 | $148,921,000 | -2.9% | 21,997,375 | +1.0% | 0.03% | -19.5% |
Q1 2020 | $153,403,000 | -28.5% | 21,790,256 | -0.3% | 0.04% | -8.9% |
Q4 2019 | $214,585,000 | -9.7% | 21,862,997 | +1.1% | 0.04% | -16.7% |
Q3 2019 | $237,547,000 | -10.5% | 21,634,550 | -5.2% | 0.05% | -8.5% |
Q2 2019 | $265,473,000 | +17.2% | 22,826,497 | -3.9% | 0.06% | +15.7% |
Q1 2019 | $226,608,000 | -3.6% | 23,753,388 | -2.6% | 0.05% | -13.6% |
Q4 2018 | $234,999,000 | -15.8% | 24,377,502 | +24.4% | 0.06% | 0.0% |
Q3 2018 | $279,227,000 | +20.3% | 19,594,880 | +1.3% | 0.06% | +13.5% |
Q2 2018 | $232,167,000 | +0.5% | 19,347,257 | +3.4% | 0.05% | 0.0% |
Q1 2018 | $230,981,000 | -15.9% | 18,702,881 | -0.9% | 0.05% | -14.8% |
Q4 2017 | $274,567,000 | -1.9% | 18,870,577 | -4.0% | 0.06% | -4.7% |
Q3 2017 | $279,781,000 | +9.9% | 19,661,338 | -1.4% | 0.06% | +6.7% |
Q2 2017 | $254,527,000 | -20.2% | 19,947,252 | -20.7% | 0.06% | -22.1% |
Q1 2017 | $318,938,000 | +21.1% | 25,152,886 | -2.5% | 0.08% | +16.7% |
Q4 2016 | $263,396,000 | -22.8% | 25,797,842 | -0.4% | 0.07% | -22.4% |
Q3 2016 | $341,083,000 | +3.7% | 25,898,416 | -0.0% | 0.08% | 0.0% |
Q2 2016 | $328,936,000 | -3.3% | 25,900,437 | +0.6% | 0.08% | -5.6% |
Q1 2016 | $340,198,000 | -14.2% | 25,753,121 | -0.1% | 0.09% | -13.5% |
Q4 2015 | $396,380,000 | +28.8% | 25,772,456 | +3.9% | 0.10% | +20.9% |
Q3 2015 | $307,678,000 | -5.4% | 24,812,669 | +4.4% | 0.09% | +2.4% |
Q2 2015 | $325,251,000 | +13.4% | 23,775,659 | -0.9% | 0.08% | +13.5% |
Q1 2015 | $286,900,000 | -10.3% | 23,988,379 | -4.2% | 0.07% | -12.9% |
Q4 2014 | $319,897,000 | +0.5% | 25,050,605 | +5.5% | 0.08% | -3.4% |
Q3 2014 | $318,436,000 | +21.1% | 23,737,264 | +44.9% | 0.09% | +23.9% |
Q2 2014 | $262,966,000 | -26.7% | 16,384,149 | -17.7% | 0.07% | -29.0% |
Q1 2014 | $358,981,000 | +9.4% | 19,910,247 | -6.2% | 0.10% | +6.4% |
Q4 2013 | $328,063,000 | -11.5% | 21,220,187 | -14.8% | 0.09% | -19.0% |
Q3 2013 | $370,534,000 | +16.4% | 24,918,241 | +1.3% | 0.12% | +11.5% |
Q2 2013 | $318,340,000 | – | 24,601,299 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 11,000,000 | $163,570,000 | 8.77% |
Blue Harbour Group | 7,262,346 | $107,991,000 | 8.08% |
RIVULET CAPITAL, LLC | 265,000 | $3,941,000 | 4.12% |
Breithorn Capital Management | 336,760 | $5,008,000 | 2.92% |
EMINENCE CAPITAL, LP | 7,791,132 | $115,854,000 | 2.56% |
Chinook Capital Management | 76,275 | $1,134,000 | 1.73% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 198,008 | $2,657,000 | 1.64% |
Adirondack Research & Management Inc. | 190,749 | $2,836,000 | 1.63% |
INTREPID CAPITAL MANAGEMENT INC /DE/ | 100,000 | $1,487,000 | 1.05% |
PRICE MICHAEL F | 477,500 | $7,100,000 | 0.94% |